Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Haas

Showing results (421-430 of 542) with videos related to

Pageof 55
Sort By:
AIDS (London, England)|August 17, 2005
Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group studyTodd Hulgan, David W Haas, Jonathan L Haines, et al.
AIDS (London, England)|December 28, 2000
Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increaseM M Lederman, R McKinnis, D Kelleher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 17, 2010
Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifsMina John, David Heckerman, Ian James, et al.
Pharmacogenetics and Genomics|December 3, 2014
Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocolsDavid S Lehmann, Heather J Ribaudo, Eric S Daar, et al.
Pneumologie (Stuttgart, Germany)|February 10, 2010
[Management of a new influenza A/H1N1 virus pandemic within the hospital. Statement of the German Society of Pneumology]T Schaberg, T Bauer, K Dalhoff, et al.
Plos Genetics|April 26, 2021
Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adultsBinglan Li, Yogasudha Veturi, Anurag Verma, et al.
The Journal of Infectious Diseases|August 2, 2014
Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfectionKelly E Dooley, Paolo Denti, Neil Martinson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2023
The Tennessee Center for AIDS Research HIV Research Training Program for Minority High School and Undergraduate Students: Development, Implementation, and Early OutcomesJohn R Koethe, Angela Eeds, LaMonica V Stewart, et al.
Research Square|January 7, 2025
Pharmacogenomic associations with HIV-1 virologic suppression in TB/HIV patientsFelipe Ridolfi, Gustavo Amorim, David W Haas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2006
Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaborationDavid W Haas, John A Bartlett, Janet W Andersen, et al.
Pageof 55

Showing results (421-430 of 542) with videos related to

Sort By:
Pageof 55
AIDS (London, England)|August 17, 2005
Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group studyTodd Hulgan, David W Haas, Jonathan L Haines, et al.
AIDS (London, England)|December 28, 2000
Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increaseM M Lederman, R McKinnis, D Kelleher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 17, 2010
Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifsMina John, David Heckerman, Ian James, et al.
Pharmacogenetics and Genomics|December 3, 2014
Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocolsDavid S Lehmann, Heather J Ribaudo, Eric S Daar, et al.
Pneumologie (Stuttgart, Germany)|February 10, 2010
[Management of a new influenza A/H1N1 virus pandemic within the hospital. Statement of the German Society of Pneumology]T Schaberg, T Bauer, K Dalhoff, et al.
Plos Genetics|April 26, 2021
Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adultsBinglan Li, Yogasudha Veturi, Anurag Verma, et al.
The Journal of Infectious Diseases|August 2, 2014
Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfectionKelly E Dooley, Paolo Denti, Neil Martinson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2023
The Tennessee Center for AIDS Research HIV Research Training Program for Minority High School and Undergraduate Students: Development, Implementation, and Early OutcomesJohn R Koethe, Angela Eeds, LaMonica V Stewart, et al.
Research Square|January 7, 2025
Pharmacogenomic associations with HIV-1 virologic suppression in TB/HIV patientsFelipe Ridolfi, Gustavo Amorim, David W Haas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2006
Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaborationDavid W Haas, John A Bartlett, Janet W Andersen, et al.
Pageof 55